GEMZ Clinical Trial of Fenfluramine in Patients With CDKL5 Deficiency Disorder by Madaline Spencer| Published on: May 8, 2026

GEMZ Clinical Trial of Fenfluramine in Patients With CDKL5 Deficiency Disorder by Madaline Spencer| Published on: May 8, 2026 Brian Moseley, MD, Senior Medical Director at UCB, discusses the GEMZ clinical trial of fenfluramine in patients with CDKL5 deficiency disorder (CDD). https://checkrare.com/gemz-clinical-trial-of-fenfluramine-in-patients-with-cdkl5-deficiency-disorder/